| 68Ga-PSMA-11 PET imaging of response to androgen receptor inhibition: first human experience TA Hope, C Truillet, EC Ehman, A Afshar-Oromieh, R Aggarwal, CJ Ryan, ... Journal of Nuclear Medicine 58 (1), 81-84, 2017 | 204 | 2017 |
| Long-Term in Vivo Clearance of Gadolinium-Based AGuIX Nanoparticles and Their Biocompatibility after Systemic Injection L Sancey, S Kotb, C Truillet, F Appaix, A Marais, E Thomas, ... ACS nano 9 (3), 2477-2488, 2015 | 164 | 2015 |
| A Top‐Down synthesis route to ultrasmall multifunctional Gd‐Based silica nanoparticles for theranostic applications A Mignot, C Truillet, F Lux, L Sancey, C Louis, F Denat, F Boschetti, ... Chemistry–A European Journal 19 (19), 6122-6136, 2013 | 162 | 2013 |
| AGuIX® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine F Lux, VL Tran, E Thomas, S Dufort, F Rossetti, M Martini, C Truillet, ... The British journal of radiology 92 (1093), 20180365, 2019 | 159 | 2019 |
| Development of a stress response therapy targeting aggressive prostate cancer HG Nguyen, CS Conn, Y Kye, L Xue, CM Forester, JE Cowan, AC Hsieh, ... Science translational medicine 10 (439), eaar2036, 2018 | 146 | 2018 |
| X-ray-induced singlet oxygen activation with nanoscintillator-coupled porphyrins AL Bulin, C Truillet, R Chouikrat, F Lux, C Frochot, D Amans, G Ledoux, ... The Journal of Physical Chemistry C 117 (41), 21583-21589, 2013 | 144 | 2013 |
| Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment G Le Duc, S Roux, A Paruta-Tuarez, S Dufort, E Brauer, A Marais, ... Cancer nanotechnology 5, 1-14, 2014 | 130 | 2014 |
| Imaging PD-L1 expression with immunoPET C Truillet, HLJ Oh, SP Yeo, CY Lee, LT Huynh, J Wei, MFL Parker, ... Bioconjugate chemistry 29 (1), 96-103, 2018 | 124 | 2018 |
| Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins AJ Martinko, C Truillet, O Julien, JE Diaz, MA Horlbeck, G Whiteley, ... Elife 7, e31098, 2018 | 85 | 2018 |
| Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade H Lue, J Podolak, K Kolahi, L Cheng, S Rao, D Garg, CH Xue, JK Rantala, ... Genes & development 31 (20), 2067-2084, 2017 | 70 | 2017 |
| Functionalization of Small Rigid Platforms with Cyclic RGD Peptides for Targeting Tumors Overexpressing αvβ3-Integrins J Morlieras, S Dufort, L Sancey, C Truillet, A Mignot, F Rossetti, ... Bioconjugate chemistry 24 (9), 1584-1597, 2013 | 65 | 2013 |
| [11 C] Ascorbic and [11 C] dehydroascorbic acid, an endogenous redox pair for sensing reactive oxygen species using positron emission tomography VN Carroll, C Truillet, B Shen, RR Flavell, X Shao, MJ Evans, ... Chemical Communications 52 (27), 4888-4890, 2016 | 51 | 2016 |
| 68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy P Bouziotis, D Stellas, E Thomas, C Truillet, C Tsoukalas, F Lux, ... Nanomedicine 12 (13), 1561-1574, 2017 | 48 | 2017 |
| Bifunctional polypyridyl-Ru (II) complex grafted onto gadolinium-based nanoparticles for MR-imaging and photodynamic therapy C Truillet, F Lux, J Moreau, M Four, L Sancey, S Chevreux, G Boeuf, ... Dalton Transactions 42 (34), 12410-12420, 2013 | 45 | 2013 |
| Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using 89Zr … VL Tran, A Novell, N Tournier, M Gerstenmayer, A Schweitzer-Chaput, ... Journal of controlled release 328, 304-312, 2020 | 44 | 2020 |
| Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: toward identification of optimal treatment windows DL Nguyen, C Wimberley, C Truillet, B Jego, F Caillé, G Pottier, ... Epilepsia 59 (6), 1234-1244, 2018 | 44 | 2018 |
| Caged [18F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography RR Flavell, C Truillet, MK Regan, T Ganguly, JE Blecha, J Kurhanewicz, ... Bioconjugate chemistry 27 (1), 170-178, 2016 | 42 | 2016 |
| A Preclinical Assessment of 89Zr-atezolizumab Identifies a Requirement for Carrier Added Formulations Not Observed with 89Zr-C4 A Moroz, CY Lee, Y Wang, JC Hsiao, N Sevillano, C Truillet, CS Craik, ... Bioconjugate chemistry 29 (10), 3476-3482, 2018 | 37 | 2018 |
| Ultrasmall particles for Gd‐MRI and 68Ga‐PET dual imaging C Truillet, P Bouziotis, C Tsoukalas, J Brugière, M Martini, L Sancey, ... Contrast media & molecular imaging 10 (4), 309-319, 2015 | 36 | 2015 |
| Synthesis and Characterization of 89Zr-Labeled Ultrasmall Nanoparticles C Truillet, E Thomas, F Lux, LT Huynh, O Tillement, MJ Evans Molecular pharmaceutics 13 (7), 2596-2601, 2016 | 33 | 2016 |
